Registered entities
Evox Therapeutics Limited
Reg. No. 10076821United Kingdom
Innovation
33 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Mechanical engineering; filing pace slowing. Cited 737 times.
| Year | Filings |
|---|---|
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 12 |
| 2019 | 18 |
| 2020 | 15 |
| 2021 | 16 |
| 2022 | 15 |
| 2023 | 12 |
| 2024 | 9 |
| 2025 | 5 |
| 2026 | 2 |
Social engagement
Social engagement: 13.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
28 investors on record; lead investors include Gates, Redmile Group, Oxford Science Enterprises.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 21% |
| Private equity | 3 | 11% |
| Accelerator & incubator | 1 | 4% |
| Bank & private debt | 1 | 4% |
| Other / undisclosed | 17 | 61% |
Recent activity
20 Jun 2026
Event
BIO International Convention
26 May 2026
Event
UK Biotech Day 2026
4 May 2026
Event
Bio€quity Europe
